Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
Authors
Keywords
-
Journal
GUT
Volume -, Issue -, Pages gutjnl-2020-323663
Publisher
BMJ
Online
2021-03-20
DOI
10.1136/gutjnl-2020-323663
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiviral therapy in the palliative setting of HCC (BCLC B and C)
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
- (2020) Angelo Sangiovanni et al. JOURNAL OF HEPATOLOGY
- Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
- (2019) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
- (2019) Marc G. Ghany et al. HEPATOLOGY
- Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
- (2018) Nicolás Merchante et al. AIDS
- Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy
- (2018) N. Saraiya et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The development of hepatocellular carcinoma in HCV infected patients treated with DAA: A comprehensive analysis
- (2018) Peng Huang et al. CARCINOGENESIS
- De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus
- (2018) Ashraf O. Abdelaziz et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis
- (2018) C. Masetti et al. JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis
- (2018) M. El Kassas et al. JOURNAL OF VIRAL HEPATITIS
- Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments
- (2018) Hidenori Toyoda et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
- (2018) Elisabetta Degasperi et al. Clinical Gastroenterology and Hepatology
- Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
- (2018) Mizuki Nishibatake Kinoshita et al. JOURNAL OF HEPATOLOGY
- Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma
- (2017) Alexander Gerbes et al. GUT
- Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy
- (2017) Pei-Chien Tsai et al. JOURNAL OF HEPATOLOGY
- Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer
- (2017) L. Cavalletto et al. JOURNAL OF HEPATOLOGY
- DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment
- (2017) R. Villani et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
- (2017) Philippe Kolly et al. JOURNAL OF HEPATOLOGY
- Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
- (2017) Jose Luis Calleja et al. JOURNAL OF HEPATOLOGY
- Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
- (2017) Hiroko Nagata et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
- (2017) Reem Waziry et al. JOURNAL OF HEPATOLOGY
- Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
- (2017) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
- (2017) Stacey B. Prenner et al. JOURNAL OF HEPATOLOGY
- Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
- (2017) Claudio Zavaglia et al. JOURNAL OF HEPATOLOGY
- Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?
- (2017) José Ríos et al. SEMINARS IN LIVER DISEASE
- Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis
- (2016) Sashidhar Manthravadi et al. INTERNATIONAL JOURNAL OF CANCER
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma
- (2016) Tatsuya Minami et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
- (2016) JOURNAL OF HEPATOLOGY
- The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt
- (2011) Patrick Royston et al. STATISTICS IN MEDICINE
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
- A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003
- (2007) Peter C. Austin STATISTICS IN MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started